The scandal over Kobayashi Pharmaceutical’s beni kōji (red yeast rice) supplements has put a spotlight on regulatory inadequacies that prevented Japan from swiftly addressing concerns related to foods with health-enhancing claims — despite recent moves to step up vigilance.
About the Author
